Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer

por Chao, Tai-Kuang, Huang, Tien-Shuo, Liao, Yu-Ping, Huang, Rui-Lan, Su, Po-Hsuan, Shen, Hueng-Yuan, Lai, Hung-Cheng, Wang, Yu-Chi
Publicado 2017